449 related articles for article (PubMed ID: 25539046)
21. Type and pattern of illicit drug use and access to health care services for HIV-infected people.
Sohler NL; Wong MD; Cunningham WE; Cabral H; Drainoni ML; Cunningham CO
AIDS Patient Care STDS; 2007; 21 Suppl 1():S68-76. PubMed ID: 17563292
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?
Stillemans G; Belkhir L; Hesselink DA; Haufroid V; Elens L
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):601-611. PubMed ID: 29775551
[TBL] [Abstract][Full Text] [Related]
23. Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.
Ande A; McArthur C; Kumar A; Kumar S
Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1453-64. PubMed ID: 23822755
[TBL] [Abstract][Full Text] [Related]
24. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
Lucas GM
Life Sci; 2011 May; 88(21-22):948-52. PubMed ID: 20888839
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.
Nachega JB; Hsu AJ; Uthman OA; Spinewine A; Pham PA
AIDS; 2012 Jul; 26 Suppl 1():S39-53. PubMed ID: 22781176
[TBL] [Abstract][Full Text] [Related]
26. All that glitters: the ups and downs of methamphetamine.
Halkitis PN; Galatowitsch P
Body Posit; 2002; 15(5):36-7. PubMed ID: 12458555
[No Abstract] [Full Text] [Related]
27. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
[TBL] [Abstract][Full Text] [Related]
28. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
[TBL] [Abstract][Full Text] [Related]
29. Effects of illicit drug use on adherence to prescribed antiretroviral medication.
Rosen MI; Rigsby MO; Dieckhaus KD; Cramer JA
Am J Addict; 2003; 12(5):455-8. PubMed ID: 14660159
[TBL] [Abstract][Full Text] [Related]
30. Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings.
Chastain DB; Franco-Paredes C; Stover KR
J Clin Pharmacol; 2017 Nov; 57(11):1387-1399. PubMed ID: 28884831
[TBL] [Abstract][Full Text] [Related]
31. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
Celentano DD; Lucas G
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
[TBL] [Abstract][Full Text] [Related]
32. Methadone and antiretroviral medications, part II.
Gourevitch MN; Friedland GH
AIDS Clin Care; 1999 May; 11(5):37, 43, 45-6. PubMed ID: 11367102
[TBL] [Abstract][Full Text] [Related]
33. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
[TBL] [Abstract][Full Text] [Related]
35. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.
Langness J; Cook PF; Gill J; Boggs R; Netsanet N
J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074
[TBL] [Abstract][Full Text] [Related]
36. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
Grierson J; Koelmeyer RL; Smith A; Pitts M
HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
[TBL] [Abstract][Full Text] [Related]
37. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
38. Adherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysis.
Cooke CE; Lee HY; Xing S
J Manag Care Pharm; 2014 Jan; 20(1):86-92. PubMed ID: 24372462
[TBL] [Abstract][Full Text] [Related]
39. Adverse interactions with antiretroviral agents: focus on recreational and addiction drugs.
Vassilev ZP; Marcus SM
AIDS Read; 2004 Feb; 14(2):96. PubMed ID: 15083804
[No Abstract] [Full Text] [Related]
40. Drug use and medication adherence among HIV-1 infected individuals.
Hinkin CH; Barclay TR; Castellon SA; Levine AJ; Durvasula RS; Marion SD; Myers HF; Longshore D
AIDS Behav; 2007 Mar; 11(2):185-94. PubMed ID: 16897351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
